title: Memantine for treatment-resistant OCD.
authors.forename: Michael
authors.initials: M
authors.lastname: Poyurovsky
authors.forename: Ronit
authors.initials: R
authors.lastname: Weizman
authors.forename: Abraham
authors.initials: A
authors.lastname: Weizman
authors.forename: Lorrin
authors.initials: L
authors.lastname: Koran
mesh_terms: D000328:Adult; D002997:Clomipramine / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012720:Severity of Illness Index; D013469:Sulpiride / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D002997:Clomipramine; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D008559:Memantine; D017367:Selective Serotonin Reuptake Inhibitors; D013469:Sulpiride